Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on shared a post on X:
“In this episode of the IASLC podcast, Lung Cancer Considered, Dr. Narjust Florez and I discuss ASCO26 immunotherapy highlights with Dr. Julie Brahmer and Dr. Peters Solange, focusing on bispecifics ivonescimab (HARMONi-6) and pumitamig, ADCs, and KRAS.”
Other articles about immunotherapy on OncoDaily.